Cargando…
Potential Therapeutic Use of Aptamers against HAT1 in Lung Cancer
SIMPLE SUMMARY: Lung cancer is one of the leading causes of death worldwide and the most common of all cancer types. Histone acetyltransferase 1 (HAT1) has attracted increasing interest as a potential therapeutic target due to its involvement in multiple pathologies, including cancer. Aptamers are s...
Autores principales: | Klett-Mingo, José Ignacio, Pinto-Díez, Celia, Cambronero-Plaza, Julio, Carrión-Marchante, Rebeca, Barragán-Usero, Miriam, Pérez-Morgado, María Isabel, Rodríguez-Martín, Eulalia, del Val Toledo-Lobo, María, González, Víctor M., Martín, Maria Elena |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9818519/ https://www.ncbi.nlm.nih.gov/pubmed/36612223 http://dx.doi.org/10.3390/cancers15010227 |
Ejemplares similares
-
An Aptamer against MNK1 for Non-Small Cell Lung Cancer Treatment
por: Carrión-Marchante, Rebeca, et al.
Publicado: (2023) -
An optimized MNK1b aptamer, apMNKQ2, and its potential use as a therapeutic agent in breast cancer
por: Pinto-Díez, C., et al.
Publicado: (2022) -
Deeping in the Role of the MAP-Kinases Interacting Kinases (MNKs) in Cancer
por: Pinto-Díez, Celia, et al.
Publicado: (2020) -
DNA Aptamers against Vaccinia-Related Kinase (VRK) 1 Block Proliferation in MCF7 Breast Cancer Cells
por: Carrión-Marchante, Rebeca, et al.
Publicado: (2021) -
Understanding HAT1: A Comprehensive Review of Noncanonical Roles and Connection with Disease
por: Ortega, Miguel A., et al.
Publicado: (2023)